LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: $7.48M2011: $14.47M2012: $22.18M2013: $21.23M2016: $20.76M2017: $29.84M2018: $19.78M2019: $16.02M2020: -$17.04M2021: $16.47M2022: -$22.59M2023: -$17.44M2024: $257.0K2025: -$206.0K-$206.0K
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$206.0K-180.2%
2024$257.0K+101.5%
2023-$17.44M+22.8%
2022-$22.59M-237.2%
2021$16.47M+196.7%
2020-$17.04M-206.4%
2019$16.02M-19.0%
2018$19.78M-33.7%
2017$29.84M+43.7%
2016$20.76M
2013$21.23M-4.3%
2012$22.18M+53.3%
2011$14.47M+93.4%
2010$7.48M